US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism

NAActive, not recruitingINTERVENTIONAL
Enrollment

854

Participants

Timeline

Start Date

January 27, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2026

Conditions
Pulmonary Embolism
Interventions
DEVICE

Adient absorbable filter + best practice VTE prophylaxis

Adient absorbable filter helps prevent PE during an 8 week protection period then gradually breaks down into carbon dioxide and water within 6 to 8 months. The absorbable filter does not require removal.

DEVICE

best practice VTE prophylaxis

Best practice VTE prophylaxis includes sequential compression machines, compression stockings, and anticoagulants (blood thinners) when indicated.

Trial Locations (2)

46202

IU Health University Hospital, Indianapolis

80045

University of Colorado Anschutz Medical Campus, Aurora

Sponsors

Lead Sponsor

Collaborators (2)

All Listed Sponsors
collaborator

Avania

INDUSTRY

collaborator

ICON plc

INDUSTRY

lead

Adient Medical

INDUSTRY

NCT05127915 - US Pivotal Clinical Study of the Adient Absorbable Filter for the Prevention of Pulmonary Embolism | Biotech Hunter | Biotech Hunter